Skip to main content
U.S. flag

An official website of the United States government

HHS Logo Eagle IconU.S. Department of Health and Human Services

Search Results for "poverty guidelines"

Sort by:

Displaying 1 - 15 of 15 results. 20 results shown per page. Page 1 of 1.

Medication Decisions - Right and Wrong

Publication Date
by Bruce Stuart, PhD Becky Briesacher, MA The Peter Lamy Center on Drug Therapy and Aging University of Maryland School of Pharmacy

Payment for Medicare Advantage Plans: Policy Issues and Options

Publication Date
PAYMENT FOR MEDICARE ADVANTAGE PLANS: POLICY ISSUES AND OPTIONS Office of Health PolicyOffice of the Assistant Secretary for Planning & Evaluation U.S. Department of Health & Human Services

Report to the President: Prescription Drug Coverage, Spending, Utilization, and Prices.

Publication Date
Executive Summary Prescription drugs play an ever-increasing role in modern medicine. New medications are improving health outcomes and quality of life, replacing surgery and other invasive treatments, and quickening recovery for patients who receive these treatments. As important as prescription drugs are, not everyone has access to them.

Managing the Unmanageable: Drug Payment and Utilization Management Strategies in Physician Organizations

Publication Date
by Helene Levens Lipton, Ph.D. Institute for Health Policy Studies, Department of Clinical Pharmacy University of California at San Francisco

The Effects of Congressional Proposals on Prescription Drug Costs for Medicare Beneficiaries

Publication Date
Department of Health and Human Services Office of the Assistant Secretary for Public Affairs Provides discussion and estimates of several Congressional proposals on prescription drug costs for Medicare beneficiaries.

Health Care in Transition: Technology Assessment in the Private Sector

Publication Date
Health Care in Transition: Technology Assessment in the Private Sector Prepared by: Richard Rettig of the RAND Corporation Office of the Assistant Secretary of Planning and Evaluation Agency for Health Care Policy and Research. July, 1996.

Health Care in Transition: Technology Assessment in the Private Sector

Publication Date
Health Care in Transition: Technology Assessment in the Private Sector Medical technology, broadly construed, embraces innovations in medicine--new drugs, biologics, medical devices, and procedures--as well as existing therapeutic and diagnostic capabilities.

Access and Utilization of New Antidepressant and Antipsychotic Medications

Publication Date
By: The Lewin Group

Issues in the Design and Implementation of Drug Formularies and Therapeutic Classes

Publication Date
As part of the Medicare Part D pharmacy benefit scheduled for implementation in 2006 by the Medicare Prescription Drug, Improvement, and Modernization Act (MMA), beneficiaries will have a choice of private plans administering the benefit.? Although plans are required to provide access to needed drugs, the law does not require plans to provide equal coverage for all drugs.?

Drug Utilization Trends by Therapeutic Class

Publication Date
Prepared for the Office of the Assistant Secretary for Planning and Evaluation Conference on Prescription Drug Costs and Pricing August 8-9, 2000 By

Prescription Drug Coverage, Spending, Utilization, and Prices

Publication Date
Prescription drugs play an ever-increasing role in modern medicine. New medications are improving health outcomes and quality of life, replacing surgery and other invasive treatments, and quickening recovery for patients who receive these treatments. As important as prescription drugs are, not everyone has access to them.

A Framework for Evaluating Quality Transparency Initiatives in Health Care

Publication Date
A Framework for Evaluating Quality Transparency Initiatives in Health Care Final Report Prepared by: Ha T. Tu Johanna R. Lauer April 15 , 2008

Securing the Benefits of Medical Innovation for Seniors: The Role of Prescription Drugs and Drug Coverage

Publication Date
EXECUTIVE SUMMARY Americans are living longer and healthier lives. By the year 2030, the number of Americans over the age of 65 is projected to double to 70 million. The life expectancy of the average American is increasing, and the rates of mortality, morbidity, and disability among Americans over age 65 have steadily decreased.

State Regulatory Experience with Provider-Sponsored Organizations

Publication Date
STATE REGULATORY EXPERIENCE WITH PROVIDER-SPONSORED ORGANIZATIONS FINAL REPORT Prepared under HHS Contract No. 100-93-0012 for: The US Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation

Pharmaceutical Pricing Practices, Utilization and Costs - Meeting Summary

Publication Date
By Kerry Kemp,Health Systems Research, Inc.